Medline total debt 2023–2026What is the debt to equity ratio? Debt to equity is a company's total debt divided by its shareholders' equity: how much it has borrowed for each dollar its owners have in the business.
Medline's total debt was 12.58B USD on 26 September 2026, down 24.4% on a year before. At the end of fiscal year 2025 it was 12.56B USD.
Last updated 9 Nov 2026 · Next report 24 Feb 2027
Total debt
Growth
| Fiscal year | Period ending | Total debt | Growth | Cash and short-term investments | Net cash | Debt to equity |
|---|---|---|---|---|---|---|
| Latest quarter | 26 Sept 2026 | 12.58B | -24.44% | 3.61B | -8.97B | 1.07 |
| FY2025 | 31 Dec 2025 | 12.56B | -25.67% | 1.94B | -10.62B | 1.17 |
| FY2024 | 31 Dec 2024 | 16.90B | +0.42% | 250.00M | -16.65B | 1.02 |
| FY2023 | 31 Dec 2023 | 16.83B | — | 1.59B | -15.24B | 0.99 |
| Quarter | Period ending | Total debt | Growth on a year before | Cash and short-term investments | Net cash | Debt to equity |
|---|---|---|---|---|---|---|
| Q3 FY2026 | 26 Sept 2026 | 12.58B | -24.44% | 3.61B | -8.97B | 1.07 |
| Q2 FY2026 | 27 Jun 2026 | 12.64B | -24.07% | 2.68B | -9.96B | 1.09 |
| Q1 FY2026 | 31 Mar 2026 | 12.64B | — | 2.24B | -10.40B | 1.12 |
| Q4 FY2025 | 31 Dec 2025 | 12.56B | — | 1.94B | -10.62B | 1.17 |
| Q3 FY2025 | 30 Sept 2025 | 16.65B | — | 955.00M | -15.70B | 0.97 |
| Q2 FY2025 | 30 Jun 2025 | 16.65B | — | 584.00M | -16.06B | 0.98 |
| Q1 FY2025 | 28 Mar 2025 | 0.00 | — | 0.00 | 0.00 | 0.00 |
Figures in USD at the end of each period. Net cash is cash and short-term investments less total debt; book value per share is on the diluted share count. The latest column is the most recent quarter.
Total debt counts commercial paper, term debt and lease liabilities.
See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Cash on hand,Free cash flow,Balance sheet
Common questions about Medline's debt
Source: Financial Modeling Prep
